Peanut allergy reduction in high-risk pediatric patients

被引:4
作者
Hopper, Jaime [1 ]
Hopp, Courtney [1 ]
Durbin, Jessica [2 ]
机构
[1] Indiana Univ, Hlth Methodist Hosp, Indianapolis, IN 46204 USA
[2] Indiana State Univ, Terre Haute, IN 47809 USA
关键词
allergy; food allergies; immunotherapy; oral immunotherapy; peanut allergy; pediatric; prevention;
D O I
10.1097/01.NPR.0000530210.24654.36
中图分类号
R47 [护理学];
学科分类号
1011 ;
摘要
The prevalence of food allergies has doubled in the past 10 years. Peanut allergies are a significant public health issue and are the primary reason for food-related anaphylactic reactions that result in death. Evidence supports that early introduction of the peanut protein (or in combination with immunotherapy) to the highly allergic may safely desensitize patients, which could lead to less adverse allergic reactions and alter allergy management overall.
引用
收藏
页码:35 / 39
页数:5
相关论文
共 50 条
  • [11] The development of allergy in high-risk children
    Burr, ML
    Merrett, TG
    Dunstan, FDJ
    Maguire, MJ
    CLINICAL AND EXPERIMENTAL ALLERGY, 1997, 27 (11) : 1247 - 1253
  • [12] Dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma
    Mora, Jaume
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (05) : 647 - 653
  • [13] Identifying infants at high risk of peanut allergy: The Learning Early About Peanut Allergy (LEAP) screening study
    Du Toit, George
    Roberts, Graham
    Sayre, Peter H.
    Plaut, Marshall
    Bahnson, Henry T.
    Mitchell, Herman
    Radulovic, Suzana
    Chan, Susan
    Fox, Adam
    Turcanu, Victor
    Lack, Gideon
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2013, 131 (01) : 135 - U215
  • [14] Investigation of gut microbiota in pediatric patients with peanut allergy in outpatient settings
    Li, Shouming
    Huang, Jingyi
    Xie, Yunyun
    Wang, Di
    Tan, Xin
    Wang, Yufan
    FRONTIERS IN PEDIATRICS, 2025, 13
  • [15] Ondansetron dose response curve in high-risk pediatric patients
    Lawhorn, CD
    Kymer, PJ
    Stewart, FC
    Stoner, JM
    Shirey, R
    Volpe, P
    JOURNAL OF CLINICAL ANESTHESIA, 1997, 9 (08) : 637 - 642
  • [16] Pediatric Patients with Asthma: A High-Risk Population for Subsequent Hospitalization
    Shaw, Michele R.
    Daratha, Kenn B.
    Odom-Maryon, Tamara
    Bindler, Ruth C.
    JOURNAL OF ASTHMA, 2013, 50 (06) : 548 - 554
  • [17] The safety of dinutuximab for the treatment of pediatric patients with high-risk neuroblastoma
    Greenwood, Katie L.
    Foster, Jennifer H.
    EXPERT OPINION ON DRUG SAFETY, 2018, 17 (12) : 1257 - 1262
  • [18] Current state and advances in desensitization for peanut allergy in pediatric age
    Foti Randazzese, Simone
    Panasiti, Ilenia
    Caminiti, Lucia
    Catamero, Francesco
    Landi, Massimo
    De Filippo, Maria
    Votto, Martina
    Olcese, Roberta
    Favuzza, Filippo
    Giovannini, Mattia
    Barberi, Salvatore
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2024, 35 (04)
  • [19] Maternal peanut consumption and risk of peanut allergy in childhood
    Abrams, Elissa M.
    Sicherer, Scott H.
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2018, 190 (27) : E814 - E815
  • [20] Dinutuximab: A Novel Immunotherapy in the Treatment of Pediatric Patients With High-Risk Neuroblastoma
    Bartholomew, Joy
    Washington, Tanea
    Bergeron, Sharon
    Nielson, Danelle
    Saggio, Jennifer
    Quirk, Lindsay
    JOURNAL OF PEDIATRIC ONCOLOGY NURSING, 2017, 34 (01) : 5 - 12